Analyze Diet

Topic:Imidocarb Dipropionate

Imidocarb dipropionate is a pharmaceutical compound used in veterinary medicine, particularly for the treatment of certain parasitic infections in horses, such as babesiosis. It functions as an antiparasitic agent, interfering with the metabolic processes of the parasites, thereby aiding in their elimination from the host. In equine medicine, its use is carefully monitored due to its pharmacokinetic properties and potential side effects. Research on imidocarb dipropionate includes studies on its efficacy, dosage optimization, safety profile, and the management of associated adverse reactions in horses. This page compiles peer-reviewed research studies and scholarly articles that explore the application, pharmacodynamics, and clinical outcomes of imidocarb dipropionate in equine health management.
Tafenoquine succinate inhibits the growth of the equine piroplasmosis hemoparasites Theileria equi and Babesia caballi.
Parasites & vectors    January 27, 2026   Volume 19, Issue 1 61 doi: 10.1186/s13071-026-07262-y
Cardillo NN, Villarino NF, Kappmeyer LS, Chung CJ, Suarez CE, Bastos RG.Equine piroplasmosis (EP) is a tick-borne disease of equids caused by the intraerythrocytic apicomplexan parasites Theileria equi, Babesia caballi and the recently identified Theileria haneyi. Acute cases can be severe, with anemia, jaundice, abortion or sudden death. Survivors remain lifelong carriers, serving as reservoirs for tick-borne and iatrogenic transmission. No vaccines are currently available, and control strategies rely heavily on accurate diagnostics and chemotherapeutic intervention. Imidocarb dipropionate (ID) is the current standard of care for both acute treatment and radical ...
[Equine piroplasmosis: Case descriptions and overview of the epidemiological situation in Europe with focus on Germany].
Tierarztliche Praxis. Ausgabe G, Grosstiere/Nutztiere    December 4, 2024   doi: 10.1055/a-2457-5516
Axt CW, Springer A, von Luckner J, Naucke TJ, Müller E, Strube C, Schäfer I.Equine piroplasmosis (EP) is caused by (.) and (.) and is transmitted by hard ticks. Predominantly, the Mediterranean region is known as being endemic for both pathogens in Europe. However, autochthonous infections in central European countries such as Germany can no longer be ruled out due to individual case reports in horses without any stays abroad as well as the geographical expansion of the habitats of different tick species. The case reports presented underline the risk of infection for horses travelling to endemic areas and in horses imported from such areas to non-endemic countries...
New insights in the diagnosis and treatment of equine piroplasmosis: pitfalls, idiosyncrasies, and myths.
Frontiers in veterinary science    August 14, 2024   Volume 11 1459989 doi: 10.3389/fvets.2024.1459989
Mendoza FJ, Pérez-Écija A, Kappmeyer LS, Suarez CE, Bastos RG.Equine piroplasmosis (EP) is a global tick-borne disease of equids caused by the intraerythrocytic apicomplexan parasites and , and the more recently discovered . These parasites can be transmitted by several tick species, including , , and , but iatrogenic and vertical transmission are also common. Clinical signs of EP include poor performance, fever, icterus, abortions, among others, and peracute or acute forms of infection are associated with high mortality in non-endemic areas. EP is a reportable disease and represents an important barrier for the international trade of horses and other e...
Babesiosis: Current status and future perspectives in Pakistan and chemotherapy used in livestock and pet animals.
Heliyon    June 18, 2023   Volume 9, Issue 6 e17172 doi: 10.1016/j.heliyon.2023.e17172
Azhar M, Gadahi JA, Bhutto B, Tunio S, Vistro WA, Tunio H, Bhutto S, Ram T.Babesiosis is a protozoal disease affect livestock and pet animals such as cattle, buffaloes, sheep, goats, horses, donkeys, mules, dogs, and cats. It causes severe economic losses in livestock as well as in pet animals. A large number of dairy animals are imported in order to fulfill the demands of milk, milk, meat and its products. In addition, different pet animals are transported from Pakistan to various parts of the world, therefore, it is important to identify the current status and distribution of babesiosis throughout Pakistan in order to control the disease and draw attention for futu...
Clinical Progression of Theileria haneyi in Splenectomized Horses Reveals Decreased Virulence Compared to Theileria equi.
Pathogens (Basel, Switzerland)    February 16, 2022   Volume 11, Issue 2 254 doi: 10.3390/pathogens11020254
Sears KP, Knowles DP, Fry LM.The global importance of the hemoparasite to equine health was recently shown by its resistance to imidocarb dipropionate (ID) and its interference with clearance by ID in some co-infected horses. Genetic characterization of revealed marked genomic reduction compared to , and initial experiments demonstrated reduced clinical severity in spleen-intact horses. Furthermore, in early experiments, splenectomized horses survived infection and progressed to an asymptomatic carrier state, in stark contrast to the high fatality rate of in splenectomized horses. Thus, we hypothesized that is less ...
Anti-piroplasmic activity of novobiocin as heat shock protein 90 inhibitor against in vitro cultured Theileria equi and Babesia caballi parasites.
Ticks and tick-borne diseases    February 27, 2021   Volume 12, Issue 4 101696 doi: 10.1016/j.ttbdis.2021.101696
Suthar A, Maji C, Gopalkrishnan A, Raval SH, Kumar R, Kumar S.Theileria equi and Babesia caballi are the causative agents of equine piroplasmosis (EP). Currently, imidocarb dipropionate (ID) is the only available drug for treating the clinical form of EP. Serious side effects and incomplete clearance of infection is a major drawback of ID. Heat-shock proteins (Hsp) play a vital role in the life cycle of these haemoprotozoans by preventing alteration in protein conformation. These Hsp are activated during transmission of EP sporozoites from the tick vector (poikilotherm) to the natural host (homeotherm) and facilitate parasite survival. In the present stu...
Imidocarb Dipropionate Lacks Efficacy against Theileria haneyi and Fails to Consistently Clear Theileria equi in Horses Co-Infected with T. haneyi.
Pathogens (Basel, Switzerland)    December 10, 2020   Volume 9, Issue 12 1035 doi: 10.3390/pathogens9121035
Sears K, Knowles D, Dinkel K, Mshelia PW, Onzere C, Silva M, Fry L.Control of , the primary cause of equine theileriosis, is largely reliant on acaracide use and chemosterilization with imidocarb dipropionate (ID). However, it is currently unknown if ID is effective against , the recently identified second causative agent of equine theileriosis, or if the drug maintains effectiveness against in the presence of co-infection. The purpose of this study was to address these questions using ID treatment of the following three groups of horses: (1) five infected horses; (2) three - infected horses; and (3) three - infected horses. Clearance was first evaluated u...
Endochin-like quinolone-300 and ELQ-316 inhibit Babesia bovis, B. bigemina, B. caballi and Theileria equi.
Parasites & vectors    December 3, 2020   Volume 13, Issue 1 606 doi: 10.1186/s13071-020-04487-3
Silva MG, Bastos RG, Stone Doggett J, Riscoe MK, Pou S, Winter R, Dodean RA, Nilsen A, Suarez CE.The most common apicomplexan parasites causing bovine babesiosis are Babesia bovis and B. bigemina, while B. caballi and Theileria equi are responsible for equine piroplasmosis. Treatment and control of these diseases are usually achieved using potentially toxic chemotherapeutics, such as imidocarb diproprionate, but drug-resistant parasites are emerging, and alternative effective and safer drugs are needed. The endochin-like quinolones (ELQ)-300 and ELQ-316 have been proven to be safe and efficacious against related apicomplexans, such as Plasmodium spp., with ELQ-316 also being effective aga...
Efficacy of oral Cynara scolymus and Silybum marianum on toxicity of imidocarb dipropionate in horses.
Veterinary record open    November 5, 2020   Volume 7, Issue 1 e000416 doi: 10.1136/vetreco-2020-000416
Jaramillo FM, Piñeros DDV, Corrêa RR, Pogliani FC, Cogliati B, Baccarin RYA.Despite hepatotoxic effects, imidocarb dipropionate is the drug of choice for treatment of equine piroplasmosis. It is important, therefore, to identify adjuvant therapies that may improve the safety of imidocarb dipropionate by reducing the risk of liver damage during its use. The aim of the present study was to evaluate the hepatoprotective and hepatoregulatory effects of treatment with and during administration of imidocarb dipropionate. Methods: Ten healthy horses, seroconverted to by C-ELISA, were treated with 5 mg/kg/day of imidocarb dipropionate for three consecutive days. The study ...
[Theileria equi-infection in 2 German horses returning from a trail ride in southern France].
Tierarztliche Praxis. Ausgabe G, Grosstiere/Nutztiere    April 23, 2020   Volume 48, Issue 2 124-129 doi: 10.1055/a-1110-2998
Springer A, Ehrmann C, Lembcke M, Roscher K, Strube C.Equine piroplasmosis, caused by the protozoan pathogens or , is endemic in many (sub-)tropical regions worldwide, including Southern Europe. In Germany, it mainly plays a role as an imported parasitosis. Nevetherless, tick species with known vector potential for equine piroplasms occur in Germany. Thus, a long-term establishment of autochthonous cycles after introduction via infected equids or ticks cannot be excluded. In the present case, 2 horses developed clinical infection after returning from a trail riding trip to southern France. During treatment, a feeding tick was discovered on one ...
Parasitological and molecular diagnostic of a clinical Babesia caballi outbreak in Southern Romania.
Parasitology research    May 15, 2018   Volume 117, Issue 7 2333-2339 doi: 10.1007/s00436-018-5899-2
Ionita M, Nicorescu IM, Pfister K, Mitrea IL.Equine piroplasmosis (EP) is a tick-borne disease of equids caused by Babesia caballi and/or Theileria equi, which is endemic in many tropical and temperate areas of the world. However, clinical outbreaks of EP in Romania during the last decades have not been reported Therefore, the aim of this paper is (i) to describe a clinical B. caballi outbreak in horses on several farms in Southern Romania using a diagnostic and therapeutic approach and (ii) the molecular diagnostic of EP in an endemic area of Romania. In the first case, a 10-month-old stallion male was presented with lethargy, anorexia,...
In vitro growth inhibitory efficacy of some target specific novel drug molecules against Theileria equi.
Veterinary parasitology    December 29, 2015   Volume 217 1-6 doi: 10.1016/j.vetpar.2015.12.024
Gopalakrishnan A, Maji C, Dahiya RK, Suthar A, Kumar R, Gupta AK, Dimri U, Kumar S.The in vitro growth inhibitory efficacies of five drug molecules against Theileria equi were evaluated in in vitro cultured parasites. A continuous microaerophilic stationary-phase culture (MASP) system was established for propagation of T. equi parasites. This in vitro culture system was used to assess the growth inhibitory effect of harmaline hydrochloride dihydrate (HHD), hexadecyltrimethylammonium bromide (HDTAB), hesparidin methyl chalcone (HMC), andrographolide and imidocarb dipropionate against T. equi. The 50% inhibitory concentration value of HHD, HDTAB, HMC, and imidocarb dipropionat...
Theileria equi isolates vary in susceptibility to imidocarb dipropionate but demonstrate uniform in vitro susceptibility to a bumped kinase inhibitor.
Parasites & vectors    January 20, 2015   Volume 8 33 doi: 10.1186/s13071-014-0611-6
Hines SA, Ramsay JD, Kappmeyer LS, Lau AO, Ojo KK, Van Voorhis WC, Knowles DP, Mealey RH.The apicomplexan hemoparasite Theileria equi is a causative agent of equine piroplasmosis, eradicated from the United States in 1988. However, recent outbreaks have sparked renewed interest in treatment options for infected horses. Imidocarb dipropionate is the current drug of choice, however variation in clinical response to therapy has been observed. Methods: We quantified the in vitro susceptibility of two T. equi isolates and a lab generated variant to both imidocarb dipropionate and a bumped kinase inhibitor compound 1294. We also evaluated the capacity of in vitro imidocarb dipropionate ...
Evaluation of the use of atropine sulfate, a combination of butylscopolammonium bromide and metamizole sodium, and flunixin meglumine to ameliorate clinical adverse effects of imidocarb dipropionate in horses.
American journal of veterinary research    October 31, 2013   Volume 74, Issue 11 1404-1408 doi: 10.2460/ajvr.74.11.1404
Abutarbush SM, Alfaqeeh SM, Mustafa G, Qura'n L, Al-Majali AM.To evaluate the ability of atropine sulfate, butylscopolammonium bromide combined with metamizole sodium, and flunixin meglumine to ameliorate the clinical adverse effects of imidocarb dipropionate in horses. Methods: 28 horses with piroplasmosis. Methods: 28 horses were randomly assigned to 4 equal groups according to the pretreatment administered. Fifteen minutes before administration of 2.4 mg of imidocarb dipropionate/kg IM, horses in the first group were pretreated with 0.02 mg of atropine sulfate/kg IV, the second group with a combination of 0.2 mg of butylscopolammonium bromide/kg IV an...
Comparison of glycopyrrolate and atropine in ameliorating the adverse effects of imidocarb dipropionate in horses.
Equine veterinary journal    March 5, 2013   Volume 45, Issue 5 625-629 doi: 10.1111/evj.12032
Donnellan CM, Page PC, Nurton JP, van den Berg JS, Guthrie AJ.Imidocarb, an effective treatment for piroplasmosis, may cause colic and diarrhoea in horses. Atropine and glycopyrrolate are anticholinergics that could reduce the adverse effects of imidocarb. However, atropine and glycopyrrolate inhibit gastrointestinal motility, potentially causing ileus and colic. Objective: To compare glycopyrrolate and atropine in ameliorating the adverse effects of imidocarb dipropionate in horses and to determine the effect of combinations of these drugs on the gastrointestinal tract. Methods: A blinded, randomised, crossover study was performed in 8 healthy horses. E...
Equine piroplasmosis treatment protocols: specific effect on orocaecal transit time as measured by the lactose 13C-ureide breath test.
Equine veterinary journal. Supplement    March 2, 2013   Issue 43 62-67 doi: 10.1111/j.2042-3306.2012.00656.x
Kutscha J, Sutton DG, Preston T, Guthrie AJ.Imidocarb dipropionate is the drug of choice for equine piroplasmosis but its administration causes severe colic and diarrhoea. An imidocarb protocol that reduces these effects is needed. Objective: 1) Quantification of the effects of imidocarb dipropionate on equine orocaecal transit time (OCTT), with and without atropine or glycopyrrolate premedication and 2) investigation of an improved pretreatment regimen for imidocarb administration. Objective: Treatment with imidocarb dipropionate will result in colic and reduced OCTT as demonstrated by the lactose 13C-ureide breath test which will be a...
Efficacy of imidocarb dipropionate in eliminating Theileria equi from experimentally infected horses.
Veterinary journal (London, England : 1997)    November 28, 2012   Volume 196, Issue 3 541-546 doi: 10.1016/j.tvjl.2012.10.025
Grause JF, Ueti MW, Nelson JT, Knowles DP, Kappmeyer LS, Bunn TO.Theileria equi, one of the causative agents of equine piroplasmosis, is endemic in many regions of the world but is considered a 'foreign' animal disease in the USA. In an effort to prevent the importation of T. equi, stringent serological screening of horses is practiced prior to entry to the USA. Current regulatory options available where horses are found to be infected include permanent quarantine with or without chemotherapy, repatriation, or euthanasia. Chemotherapeutics that eliminate infection and subsequently transmission risk are critical in the management of infected horses. In this ...
Re-emergence of the apicomplexan Theileria equi in the United States: elimination of persistent infection and transmission risk.
PloS one    September 6, 2012   Volume 7, Issue 9 e44713 doi: 10.1371/journal.pone.0044713
Ueti MW, Mealey RH, Kappmeyer LS, White SN, Kumpula-McWhirter N, Pelzel AM, Grause JF, Bunn TO, Schwartz A, Traub-Dargatz JL, Hendrickson A, Espy B....Arthropod-borne apicomplexan pathogens that cause asymptomatic persistent infections present a significant challenge due to their life-long transmission potential. Although anti-microbials have been used to ameliorate acute disease in animals and humans, chemotherapeutic efficacy for apicomplexan pathogen elimination from a persistently infected host and removal of transmission risk is largely unconfirmed. The recent re-emergence of the apicomplexan Theileria equi in U.S. horses prompted testing whether imidocarb dipropionate was able to eliminate T. equi from naturally infected horses and rem...
Identification of the piroplasms isolated from horses with clinical piroplasmosis in Poland.
Wiadomosci parazytologiczne    June 4, 2011   Volume 57, Issue 1 21-26 
Adaszek Ł, Górna M, Krzysiak M, Adaszek M, Garbal M, Winiarczyk S.The study was aimed at determining the cause of the diseases in three horses exhibiting symptoms of fever, ataxia, mucus membrane paleness, haematuria and thrombocytopenia. The PCR technique revealed the presence in the blood of 18S RNA Babesia/Theileria spp. genetic material. DNA amplification using primers RLB F2 and RLB R2 produced 430 bp size products. The sequences of these PCR products demonstrated a 95.6-97.5% similarity with the sequence of the fragment of 18S RNA Babesia equi, gene number DQ287951 in the GenBank. The treatment utilizing the subcutaneous application of the imidocarb re...
A PCR study of piroplasms in 166 dogs and 111 horses in France (March 2006 to March 2008).
Parasitology research    March 10, 2010   Volume 106, Issue 6 1339-1342 doi: 10.1007/s00436-010-1804-3
Fritz D.Positive PCR results for piroplasms were obtained on EDTA blood samples from 166 dogs and 111 horses between March 2006 and March 2008. The organisms were initially identified using common primers, followed by restriction enzyme profiles to determine the species and types of Babesia/Theileria. In 27 dogs and eight horses with positive results, the size of the specimen was insufficient to separate species/types. We identified Babesia canis canis in 105 of the 166 dogs (63%) and Theileria equi in 89 of the 111 horses (80%). Babesia caballi was also present, but rare, in only two Babesia/Theileri...
Imidocarb dipropionate clears persistent Babesia caballi infection with elimination of transmission potential.
Antimicrobial agents and chemotherapy    July 20, 2009   Volume 53, Issue 10 4327-4332 doi: 10.1128/AAC.00404-09
Schwint ON, Ueti MW, Palmer GH, Kappmeyer LS, Hines MT, Cordes RT, Knowles DP, Scoles GA.Antimicrobial treatment of persistent infection to eliminate transmission risk represents a specific challenge requiring compelling evidence of complete pathogen clearance. The limited repertoire of antimicrobial agents targeted at protozoal parasites magnifies this challenge. Using Babesia caballi as both a model and a specific apicomplexan pathogen for which evidence of the elimination of transmission risk is required for international animal movement, we tested whether a high-dose regimen of imidocarb dipropionate cleared infection from persistently infected asymptomatic horses and/or elimi...
Repeated high dose imidocarb dipropionate treatment did not eliminate Babesia caballi from naturally infected horses as determined by PCR-reverse line blot hybridization.
Veterinary parasitology    November 17, 2007   Volume 151, Issue 2-4 320-322 doi: 10.1016/j.vetpar.2007.11.010
Butler CM, Nijhof AM, van der Kolk JH, de Haseth OB, Taoufik A, Jongejan F, Houwers DJ.Imidocarb treatment of horses infected with Babesia caballi is supposed to eliminate the infection, but data on the efficacy of this treatment is scarce. The study presented here concerns four Paso Fino horses, which were imported into the island of Curacao on the basis of a piroplasmosis negative complement fixation test (CFT). Upon re-testing with an indirect fluorescent antibody test immediately after arrival in Curacao, two horses appeared to have antibodies to B. caballi and all horses had antibodies to Theileria equi. Subsequent testing with polymerase chain reaction combined with a reve...
[A literature review of equine piroplasmosis after an episode of acute babesiosis in a Dutch Standardbred foal after a stay in Normandy].
Tijdschrift voor diergeneeskunde    December 21, 2005   Volume 130, Issue 23 726-731 
Butler CM, van Gils JA, van der Kolk JH.Piroplasmosis, a disease endemic to most tropical and subtropical areas, appears to be spreading to more temperate zones. This article gives a review of equine piroplasmosis and describes an acute case of infection with Babesia caballi in a Dutch Standard bred foal after a short stay at a stud in Normandy (France). A 3-month-old stallion foal was presented with lethargy, fever of 41 degrees C, and pale mucosal membranes. Haematology revealed a low packed cell volume (14 l/l) leucytosis (25 G/l) and a high blood urea nitrogen concentration (20.1mmol/l). Infection with B. caballi was diagnosed o...
Clinical and clinicopathological changes in 6 healthy ponies following intramuscular administration of multiple doses of imidocarb dipropionate.
Journal of the South African Veterinary Association    May 20, 2005   Volume 76, Issue 1 26-32 doi: 10.4102/jsava.v76i1.390
Meyer C, Guthrie AJ, Stevens KB.Haematological variables and selected serum indices, particularly those affected by changes in renal and hepatic function, were examined in 6 healthy ponies following 4 intramuscular doses of 4 mg/kg imidocarb dipropionate administered every 72 hours. This treatment regime has been reported to sterilise experimental Babesia equi infections in horses and may have value in preventing the spread of this disease during exportation of possible carrier horses to non-endemic countries. Serum bile acids and serum gamma glutamyltransferase activity were measured to evaluate the effect of this treatment...
In-vivo therapeutic efficacy trial with artemisinin derivative, buparvaquone and imidocarb dipropionate against Babesia equi infection in donkeys.
The Journal of veterinary medical science    December 11, 2003   Volume 65, Issue 11 1171-1177 doi: 10.1292/jvms.65.1171
Kumar S, Gupta AK, Pal Y, Dwivedi SK.The therapeutic efficacy of imidocarb, artesunate, arteether, buparvaquone and arteether+buparvaquone combination was evaluated against Babesia equi of Indian origin in splenectomised donkeys with experimentally induced acute infection. Efficacies of these drugs were tested by administering each drug or drug combination to groups of donkeys (having three donkeys each group). One group of donkey was kept as untreated control for comparing the results. Parasitaemia, haematology (WBC, RBC, PCV, granulocytes and haemoglobin), biochemical parameters (SAST, SALT, alkaline phosphatase, albumin/globul...
Pharmacokinetics of imidocarb dipropionate in horses after intramuscular administration.
Equine veterinary journal    October 3, 2002   Volume 34, Issue 6 625-629 doi: 10.2746/042516402776180124
Belloli C, Crescenzo G, Lai O, Carofiglio V, Marang O, Ormas P.The objective of this study was to determine the pharmacokinetic behaviour of imidocarb in horses following a single i.m. injection at the dose commonly administered to treat Babesia caballi infections or to prevent babesiosis. Eight horses were injected i.m. with a single dose of 2.4 mg imidocarb dipropionate/kg bwt and blood, faecal, urine and milk samples were collected. For imidocarb determination, a high-performance liquid chromatographic method (HPLC) was used after weak cation-exchange solid phase, or liquid-liquid, extraction procedures. Twelve hours after treatment, no detectable plas...
Could treatment of pregnant mares prevent abortions due to equine piroplasmosis?
Journal of the South African Veterinary Association    June 16, 2000   Volume 70, Issue 2 90-91 doi: 10.4102/jsava.v70i2.760
Lewis BD, Penzhorn BL, Volkmann DH.Treatment of pregnant mares to prevent abortions due to equine piroplasmosis is a novel idea practised empirically at some Thoroughbred studs in South Africa. This paper presents the results of an investigation to ascertain whether imidocarb dipropionate crosses the equine placenta. Three pregnant mares were injected intramuscularly with imidocarb and their foetuses were mechanically aborted at varying time intervals thereafter. Imidocarb was found in foetal blood at a level similar to that in the dam's blood, suggesting that imidocarb administered to the dam would be available for anti-parasi...
Effect of sodium methyl arsinate and imidocarb dipropionate antiprotozoal drugs on the pharmacokinetic of gentamicin in equines.
DTW. Deutsche tierarztliche Wochenschrift    August 11, 1998   Volume 105, Issue 7 274-276 
Soliman GA.The pharmacokinetic behaviour of gentamicin sulphate (3.4 mg/kg bwt) was studied following its intramuscular injection to a group of horses and to another group of horses premedicated with sodium methyl arsinate (2 mg/kg bwt) or imidocarb dipropionate (4.8 mg/kg bwt). Considerable differences were observed in the pharmacokinetics of gentamicin in pre-medicated horses and in horses which had received the antibiotic alone. Peak serum concentration of gentamicin (9.85 +/- 0.05 and 11.15 +/- 0.15 micrograms/ml) were attained within 1.45 +/- 0.05 and 0.92 +/- 0.04 h in arsinate and imidocarb-medica...
Equine babesiosis associated with strenuous exercise: clinical and pathological studies in Jordan.
Veterinary parasitology    April 1, 1997   Volume 69, Issue 1-2 1-8 doi: 10.1016/s0304-4017(96)01100-4
Hailat NQ, Lafi SQ, al-Darraji AM, al-Ani FK.Clinical, haematological and pathological studies were undertaken in Jordan in a stud of 103 racing horses clinically suffering from babesiosis and apparently healthy animals. Out of 47 horses which participated in strenuous exercise, three mares showed sudden onset of immobility and reluctance to move and two mares died. Clinical examination revealed that these five horses (group 1) had fever, anorexia, weakness and severe icterus and, in two mares, haemoglobinuria. Haematological examination revealed that all five horses were heavily parasitized with Babesia equi. This was also found in four...
Equine piroplasmosis an update on diagnosis, treatment and prevention.
The British veterinary journal    March 1, 1996   Volume 152, Issue 2 139-151 doi: 10.1016/s0007-1935(96)80070-4
Brüning A.Two haemoprotozoan parasites, Babesia caballi and Babesia equi, can cause equine piroplasmosis. Due to the presence of potential tick vectors in areas so far unaffected by equine babesias, import and export regulations often require the serum testing of animals for evidence of infection. Although the complement fixation test (CFT) has been recommended for detecting the presence of antibodies to Babesia spp., it has been demonstrated to have several disadvantages, including false-positive results and low sensitivity for detecting latent infections. An enzyme-linked immunosorbent assay (ELISA) m...